Is Your Portfolio Missing These 5 High-Growth Healthcare Stocks? [Yahoo! Finance]
Veracyte, Inc. (VCYT)
Last veracyte, inc. earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.veracyte.com/investor-relations
Company Research
Source: Yahoo! Finance
What are the key trends in the healthcare sector in 2024? The key trends in the healthcare sector in 2024 include the continued adoption of digital health technologies, such as telehealth, AI-driven tools, and electronic health records (EHR), which are revolutionizing how healthcare is delivered. Additionally, there is a focus on preventive care, reduced recovery times, and improved patient outcomes, as well as growth in robotics surgery. Was this helpful? Yes No How has the healthcare sector performed in terms of stock price performance in 2024? The Zacks Medical Sector has declined 2.4% year to date, starkly contrasting with the S&P 500 Index's robust 25.8% growth. Was this helpful? Yes No What are some of the challenges facing the healthcare sector in 2024? The healthcare sector is struggling with rising medical costs, workforce shortages, and margin pressures, coupled with regulatory uncertainty. Additionally, potential policy changes under the new administr
Show less
Read more
Impact Snapshot
Event Time:
VCYT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VCYT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VCYT alerts
High impacting Veracyte, Inc. news events
Weekly update
A roundup of the hottest topics
VCYT
News
- 3 Medical Instruments Industry Stocks to Buy on the GenAI Wave [Yahoo! Finance]Yahoo! Finance
- Those who invested in Veracyte (NASDAQ:VCYT) a year ago are up 68% [Yahoo! Finance]Yahoo! Finance
- Veracyte's Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer Guidelines [Yahoo! Finance]Yahoo! Finance
- Veracyte’s Decipher Prostate Test Is Now the Only Gene Expression Test Recommended in NCCN® Prostate Cancer GuidelinesBusiness Wire
- Veracyte, Inc. (NASDAQ: VCYT) had its "neutral" rating re-affirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $37.00 price target on the stock, down previously from $38.00.MarketBeat
VCYT
Earnings
- 11/6/24 - Beat
VCYT
Sec Filings
- 12/17/24 - Form 4
- 12/13/24 - Form 144
- 12/6/24 - Form 4
- VCYT's page on the SEC website